Publicacións nas que colabora con Antonio González Martínez-Pedrayo (23)

2023

  1. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

    Frontiers in Immunology, Vol. 13

  2. Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 56-67

2021

  1. Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

  2. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  3. Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes

    Frontiers in Immunology, Vol. 11

  4. Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (Scientific Reports, (2020), 10, 1, (3355), 10.1038/s41598-020-60305-x)

    Scientific Reports

2018

  1. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 539-545

  2. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

  3. Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

    Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391

2014

  1. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 298-305

2012

  1. Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis

    Arthritis and Rheumatism, Vol. 64, Núm. 8, pp. 2460-2470

2010

  1. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model

    Arthritis Research and Therapy, Vol. 12, Núm. 6

2007

  1. Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility [3]

    Annals of the Rheumatic Diseases

2006

  1. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility

    Rheumatology, Vol. 45, Núm. 7, pp. 819-823

  2. Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2004

  1. Novel DNASE I mutations related to systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 50, Núm. 12, pp. 4070-4071

1999

  1. Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo

    Immunology, Vol. 97, Núm. 3, pp. 438-446